Literature DB >> 28913788

Suboptimal use of statins for secondary cardiovascular prevention: a "planetary" issue.

Alfonso Bellia1, David Della-Morte2,3, Davide Lauro2.   

Abstract

Mesh：

Substances：

Year:  2017        PMID： 28913788     DOI： 10.1007/s11739-017-1749-y

Source DB:  PubMed          Journal:  Intern Emerg Med        ISSN： 1828-0447            Impact factor:   3.397


× No keyword cloud information.
  11 in total

1.  2015 ACC/AHA Focused Update of Secondary Prevention Lipid Performance Measures: A Report of the American College of Cardiology/American Heart Association Task Force on Performance Measures.

Authors:  Joseph P Drozda; T Bruce Ferguson; Hani Jneid; Harlan M Krumholz; Brahmajee K Nallamothu; Jeffrey W Olin; Henry H Ting
Journal:  J Am Coll Cardiol       Date:  2015-12-14       Impact factor: 24.094

2.  How often is medication taken as prescribed? A novel assessment technique.

Authors:  J A Cramer; R H Mattson; M L Prevey; R D Scheyer; V L Ouellette
Journal:  JAMA       Date:  1989-06-09       Impact factor: 56.272

3.  2016 ESC/EAS Guidelines for the Management of Dyslipidaemias: The Task Force for the Management of Dyslipidaemias of the European Society of Cardiology (ESC) and European Atherosclerosis Society (EAS) Developed with the special contribution of the European Assocciation for Cardiovascular Prevention & Rehabilitation (EACPR).

Authors:  Alberico L Catapano; Ian Graham; Guy De Backer; Olov Wiklund; M John Chapman; Heinz Drexel; Arno W Hoes; Catriona S Jennings; Ulf Landmesser; Terje R Pedersen; Željko Reiner; Gabriele Riccardi; Marja-Riita Taskinen; Lale Tokgozoglu; W M Monique Verschuren; Charalambos Vlachopoulos; David A Wood; Jose Luis Zamorano
Journal:  Atherosclerosis       Date:  2016-09-01       Impact factor: 5.162

4.  Effectiveness of adherence to lipid lowering therapy on LDL-cholesterol in patients with very high cardiovascular risk: A real-world evidence study in primary care.

Authors:  Valeria Guglielmi; Alfonso Bellia; Serena Pecchioli; David Della-Morte; Damiano Parretti; Iacopo Cricelli; Gerardo Medea; Paolo Sbraccia; Davide Lauro; Claudio Cricelli; Francesco Lapi
Journal:  Atherosclerosis       Date:  2017-05-20       Impact factor: 5.162

5.  Trends in prescribing rate of statins at discharge and modifiable factors in patients with atherosclerotic cardiovascular disease.

Authors:  Bao-Tao Huang; Yong Peng; Fang-Yang Huang; Tian-Li Xia; Yi-Yue Gui; Yan-Biao Liao; Xiao-Bo Pu; Shi-Jian Chen; Yong Yang; Mao Chen
Journal:  Intern Emerg Med       Date:  2017-06-08       Impact factor: 3.397

6.  Adverse events associated with unblinded, but not with blinded, statin therapy in the Anglo-Scandinavian Cardiac Outcomes Trial-Lipid-Lowering Arm (ASCOT-LLA): a randomised double-blind placebo-controlled trial and its non-randomised non-blind extension phase.

Authors:  Ajay Gupta; David Thompson; Andrew Whitehouse; Tim Collier; Bjorn Dahlof; Neil Poulter; Rory Collins; Peter Sever
Journal:  Lancet       Date:  2017-05-02       Impact factor: 79.321

7.  Implications of the 2013 ACC/AHA cholesterol guidelines for adults in contemporary cardiovascular practice: insights from the NCDR PINNACLE registry.

Authors:  Thomas M Maddox; William B Borden; Fengming Tang; Salim S Virani; William J Oetgen; J Brendan Mullen; Paul S Chan; Paul N Casale; Pamela S Douglas; Fredrick A Masoudi; Steven A Farmer; John S Rumsfeld
Journal:  J Am Coll Cardiol       Date:  2014-11-19       Impact factor: 24.094

8.  Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes.

Authors:  Peter Gaede; Pernille Vedel; Nicolai Larsen; Gunnar V H Jensen; Hans-Henrik Parving; Oluf Pedersen
Journal:  N Engl J Med       Date:  2003-01-30       Impact factor: 91.245

9.  Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials.

Authors:  C Baigent; L Blackwell; J Emberson; L E Holland; C Reith; N Bhala; R Peto; E H Barnes; A Keech; J Simes; R Collins
Journal:  Lancet       Date:  2010-11-08       Impact factor: 79.321

10.  Trends in myocardial infarction secondary prevention: The National Health and Nutrition Examination Surveys (NHANES), 1999-2012.

Authors:  Nilay S Shah; Mark D Huffman; Hongyan Ning; Donald M Lloyd-Jones
Journal:  J Am Heart Assoc       Date:  2015-04-22       Impact factor: 5.501
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.